At 08:34 AM, Nifty futures on the Singapore Exchange (SGX) were trading 114.7 points, or 1.02 per cent higher at 11,359, indicating a positive start for the Indian market on Thursday.
Here's a list of stocks that may trade actively in today's session.
RIL: US private equity firm Silver Lake Partners will invest an additional Rs 1,875 crore in the retail arm of Reliance Industries, the Indian firm said in a statement on Wednesday. This brings the aggregate investment by Silver Lake and its co-investors in RRVL to Rs 9,375 crore, which will translate into a 2.13 per cent equity stake in RRVL.
PNB: Public sector Punjab National Bank (PNB) on Wednesday declared its Rs 1,203.26 crore exposure to Sintex Industries Ltd as fraud. The fraud reporting pertains to the large corporate branch at Ahmedabad zonal office, it added.
Dhanlaxmi Bank: Shareholders of Thrissur-based Dhanlaxmi Bank on Wednesday ousted managing director and CEO Sunil Gurbaxani at the bank’s annual general meeting (AGM).
Auto stocks: Shares of auto companies are expected to trade actively as automakers will start releasing their August sales numbers starting today.
Lakshmi Vilas Bank: Quashing rumours around the deal with Clix Capital and its group companies being called off and also setting aside speculations around a regulator-imposed merger, top officials of Lakshimi Vilas Bank (LVB) and Clix Capital reaffirmed their commitment to the ongoing merger talks. READ MORE
ONGC, Oil India may remain under pressure today after the government cut natural gas prices cut by 25 per cent, to be effective from today. The latest reduction in price brings it to a level last seen in 2010, when prices were set by the government.
CAMS, Chemcon Speciality Chemicals: Chemcon Speciality Chemicals will debut at the bourses after finalising issue price at the higher end at Rs 340 per share. Computer Age Management Services will also list its shares today, with the issue price fixed at Rs 1,230 per share.
PVR, Inox Leisure and leisure related stocks are expected to trade actively today after the central government announced Unlock 5.0 guidelines in which it has allowed reopening of cinema halls, theatres, and multiplexes with effect from October 15 with a maximum of 50 per cent capacity.
Natco Pharma, Lupin: Natco Pharma announced that its marketing partner, Lupin has launched Lapatinib Tablets, 250 mg, in the United States market after NATCO received the final approval for its Abbreviated New Drug Application (ANDA) from the US Federal Drug Administration (USFDA).
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU